A pilot proof of concept study of the Effects of Administration of SCFA in Rheumatoid Arthritis (EASi-RA)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Rheumatoid Arthritis
-
Age: Between 18 Year(s) - 100 Year(s)
-
Gender: Male or Female
-
Other Inclusion Criteria:
- New diagnosis of RA
- Scheduled to begin treatment with methotrexate at any dose as standard medical care
- Able and willing to provide written informed consent prior to any study specific procedures
- Age 18 years and above at time of enrollment
- Subjects not excluded based on race or ethnicity
You may not be eligible for this study if the following are true:
-
- Participants who are pregnant or are currently breastfeeding
- History of sensitivity to study compound or any of their excipients
- Previous intolerance to SCFA or related compounds
- Current (within 3 months of screening) treatment with csDMARDs
- Current or past (ever) treatment with biologic therapies
- Current antibiotic treatment (within 3 months of screening)
- Current consumption of probiotics (within 3 months of screening)
- Severe hepatic impairment
- Renal failure
- History of other autoimmune disease
- Current immunodeficiency state
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.